Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 1/20 | 0.34 |
| ▸ | PTGES | O14684 | 1/20 | 0.32 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17419746 | 0.84 | PTGES (0.33) | PTGESALOX5 | |
| SCHEMBL17419676 | 0.82 | — | — | |
| SCHEMBL11625099 | 0.77 | ALDH1A1 (0.31) | — | |
| SCHEMBL17419523 | 0.71 | — | — | |
| SCHEMBL17419522 | 0.71 | ALDH1A1 (0.32) | — | |
| SCHEMBL3154825 | 0.70 | DUSP3 (0.34) | — | |
| SCHEMBL17231977 | 0.69 | — | — | |
| SCHEMBL3162802 | 0.68 | — | — | |
| SCHEMBL17419871 | 0.68 | — | — | |
| SCHEMBL17419561 | 0.67 | ALDH1A1 (0.34) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10299476-B2 | 3′-substituted-abscisic acid derivatives | VALENT BIOSCIENCES LLC (US) | 2019-05-28 | — | — | US | disclosed |
| US-10299476-B2 | 3′-substituted-abscisic acid derivatives | VALENT BIOSCIENCES LLC (US) | 2019-05-28 | — | — | US | disclosed |
| US-20170360037-A1 | 3′-SUBSTITUTED-ABSCISIC ACID DERIVATIVES | VALENT BIOSCIENCES LLC (US) | 2017-12-21 | — | — | US | disclosed |
| US-20170360037-A1 | 3′-SUBSTITUTED-ABSCISIC ACID DERIVATIVES | VALENT BIOSCIENCES LLC (US) | 2017-12-21 | — | — | US | disclosed |
| US-20170360037-A1 | 3′-SUBSTITUTED-ABSCISIC ACID DERIVATIVES | VALENT BIOSCIENCES LLC (US) | 2017-12-21 | — | — | US | disclosed |
| US-9781930-B2 | 3′-substituted-abscisic acid derivatives | VALENT BIOSCIENCES LLC (US) | 2017-10-10 | — | — | US | disclosed |
| US-9781930-B2 | 3′-substituted-abscisic acid derivatives | VALENT BIOSCIENCES LLC (US) | 2017-10-10 | — | — | US | disclosed |
| US-9781930-B2 | 3′-substituted-abscisic acid derivatives | VALENT BIOSCIENCES LLC (US) | 2017-10-10 | — | — | US | disclosed |
| US-20160007598-A1 | 3'-SUBSTITUTED-ABSCISIC ACID DERIVATIVES | VALENT BIOSCIENCES CORPORATION | 2016-01-14 | — | — | US | disclosed |
| US-20160007598-A1 | 3'-SUBSTITUTED-ABSCISIC ACID DERIVATIVES | VALENT BIOSCIENCES CORPORATION | 2016-01-14 | — | — | US | disclosed |
| US-20160007598-A1 | 3'-SUBSTITUTED-ABSCISIC ACID DERIVATIVES | VALENT BIOSCIENCES CORPORATION | 2016-01-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170360037-A1 | 3′-SUBSTITUTED-ABSCISIC ACID DERIVATIVES | BROX, BOLA2; BOLA2B, COASY | PTPN1 3461/4885PTGES 2063/4885ALOX5 1982/4885 |
| US-20160007598-A1 | 3'-SUBSTITUTED-ABSCISIC ACID DERIVATIVES | BROX, BOLA2; BOLA2B, COASY | PTPN1 3485/4885PTGES 2055/4885ALOX5 2047/4885 |
| US-10299476-B2 | 3′-substituted-abscisic acid derivatives | BROX, BOLA2; BOLA2B, COASY | PTPN1 3461/4885PTGES 2063/4885ALOX5 1982/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.